Position
Forefront Analytics, LLC in Mirum Pharmaceuticals, Inc.
Back to the book · All holders of MIRM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.66K | $210.3K | — | — | — | 0.2% |